^Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H (May 2002). "p53AIP1 regulates the mitochondrial apoptotic pathway". Cancer Res. 62 (10): 2883–9.
PMID12019168.
Chan KT, Lung ML (2004). "Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line". Cancer Chemother. Pharmacol. 53 (6): 519–26.
doi:
10.1007/s00280-004-0767-4.
PMID15004724.
S2CID13125987.
Kövesi G, Szende B (2004). "Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia". Oncology. 65 (4): 331–6.
doi:
10.1159/000074646.
PMID14707453.
S2CID19136670.
^Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H (May 2002). "p53AIP1 regulates the mitochondrial apoptotic pathway". Cancer Res. 62 (10): 2883–9.
PMID12019168.
Chan KT, Lung ML (2004). "Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line". Cancer Chemother. Pharmacol. 53 (6): 519–26.
doi:
10.1007/s00280-004-0767-4.
PMID15004724.
S2CID13125987.
Kövesi G, Szende B (2004). "Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia". Oncology. 65 (4): 331–6.
doi:
10.1159/000074646.
PMID14707453.
S2CID19136670.